Canopy Growth (CGC) Retained Earnings (2017 - 2026)
Canopy Growth (CGC) posted Retained Earnings of -$8.1 billion for Q1 2026, down 3.12% sequentially from -$7.9 billion in Q4 2025, and down 2178469.77% YoY from N/an in Q1 2025.
Canopy Growth (CGC) Retained Earnings (2017 - 2026) Analysis & Trends
Canopy Growth has reported Retained Earnings for 10 years, with the latest figure at -$8.1 billion in Q1 2026.
- Quarterly Retained Earnings fell 2178469.77% year-over-year to -$8.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.1 billion (down 2178469.77% YoY) and the FY2026 annual result came in at -$8.1 billion, down 2178469.77% from the prior year.
- Retained Earnings slipped to -$8.1 billion in Q1 2026 per CGC's latest filing, from -$7.9 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $575527.6 in Q1 2022 and troughed at -$8.1 billion in Q1 2026.
- A 5-year average of -$6.6 billion and a median of -$7.5 billion in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2026: Retained Earnings surged 100.01% in 2022, then sank 2178469.77% in 2026.
- Over 5 years, Retained Earnings stood at -$6.7 billion in 2022, then decreased by 12.79% to -$7.5 billion in 2023, then slipped by 1.86% to -$7.6 billion in 2024, then slipped by 3.03% to -$7.9 billion in 2025, then declined by 3.12% to -$8.1 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$8.1 billion, -$7.9 billion, and -$7.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Canopy Growth | 445.49 Mn | 198.48 Mn | 16.08 Mn | -8.06 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.06 Bn |
| Mar 31, 2026 | -8.12 Bn |
| Dec 31, 2025 | -7.88 Bn |
| Sep 30, 2025 | -7.94 Bn |
| Jun 30, 2025 | -7.88 Bn |
| Mar 31, 2025 | 372,850.31 |
| Dec 31, 2024 | -7.64 Bn |
| Sep 30, 2024 | -7.76 Bn |
| Jun 30, 2024 | -7.66 Bn |
| Mar 31, 2024 | -7.69 Bn |
| Dec 31, 2023 | -7.51 Bn |
| Sep 30, 2023 | -7.47 Bn |
| Jun 30, 2023 | -7.23 Bn |
| Mar 31, 2023 | -7.15 Bn |
| Dec 31, 2022 | -6.65 Bn |
| Sep 30, 2022 | -6.73 Bn |
| Jun 30, 2022 | -6.64 Bn |
| Mar 31, 2022 | 575,527.57 |
| Dec 31, 2021 | -4.60 Bn |
| Sep 30, 2021 | -4.52 Bn |